
    
      This is an investigator initiated, open-label, uncontrolled study to prospectively
      characterize the safety and efficacy of the AeriSeal System in patients with advanced upper
      lobe predominant emphysema found to have significant collateral ventilation using the Chartis
      System.
    
  